United States — Food and Drug Administration & Joseph E. Levi
9 shared events · Importance 3 · Last updated Sep 03, 2025
Live sentiment trends, interaction importance charts, and action volume tracking available on the
NewsDesk Dashboard
Business
United States — Food and Drug Administration: The United States — Food and Drug Administration's potential non-approval of tabelecleucel's Biologics License Application due to manufacturing issues is a key factor in the lawsuit against Atara Biotherapeutics.
Joseph E. Levi: Joseph E. Levi is an attorney at Levi & Korsinsky, serving as a contact for investors interested in the class action lawsuit against Atara Biotherapeutics.
Apr 01, 2026 · 58 articles
Business
United States — Food and Drug Administration: The United States — Food and Drug Administration was mentioned in GSK plc's alleged false statements regarding its independent conclusion on the causal association between ranitidine therapy and cancer.
Feb 10, 2025 · 34 articles
Business
Joseph E. Levi: Joseph E. Levi is an attorney at Levi & Korsinsky, serving as a contact for investors interested in the class action lawsuit against UroGen Pharma.
Jun 05, 2025 · 6 articles
Business
Joseph E. Levi: Joseph E. Levi is an attorney at Levi & Korsinsky, involved in the class action lawsuit against PepGen.
Jun 11, 2025 · 17 articles
Business
Joseph E. Levi: Joseph E. Levi is an attorney at Levi & Korsinsky, involved in notifying investors about the class action lawsuit against Coya Therapeutics.
Jun 27, 2025 · 44 articles
Business
Joseph E. Levi: Joseph E. Levi is an attorney at Levi & Korsinsky, LLP, involved in the class action lawsuit against Replimune Group.
Jul 25, 2025 · 26 articles
NEWSDESK
Explore this relationship live
Track how United States — Food and Drug Administration and Joseph E. Levi interact across events, view sentiment trends, and discover connected entities.
Open Dashboard